is hims still selling compounded semaglutide cancels plans to sell GLP-1 pill after FDA backlash Hims Online GLP-1 Clinic Review:

In 2025 Boccard partnered with a pharmaceutical manufacturer to design and deliver a complete GLP1 production installation supporting the clients expansion plan

Eli Lilly now has a GLP-1 Diabetes approved treatment on the market under the Diabetes brand name, Mounjaro, that seems to be as if not more effective as Semaglutide in terms of weight loss when used for obesity

The savings are subject to monthly and annual caps

We need cardiovascular outcomes data

The organising principle On average, insulin resistance tends to improve most through (1) movement, (2) body fat reduction where appropriate, and (3) reducing glucotoxicity